Giaccone G - Search Results

1

LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers.

Chen C, Liu WR, Zhang B, Zhang LM, Li CG, Liu C, Zhang H, Huo YS, Ma YC, Tian PF, Qi Q, Li JJ, Tang Z, Zhang ZF, Giaccone G, Yue DS, Wang CL. Chen C, et al. Among authors: giaccone g. Cancer Lett. 2020 Aug 28;486:58-70. doi: 10.1016/j.canlet.2020.05.009. Epub 2020 May 18. Cancer Lett. 2020. PMID: 32439420

2

A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.

Reckamp KL, Giaccone G, Camidge DR, Gadgeel SM, Khuri FR, Engelman JA, Koczywas M, Rajan A, Campbell AK, Gernhardt D, Ruiz-Garcia A, Letrent S, Liang J, Taylor I, O'Connell JP, Jänne PA. Reckamp KL, et al. Among authors: giaccone g. Cancer. 2014 Apr 15;120(8):1145-54. doi: 10.1002/cncr.28561. Epub 2014 Feb 5. Cancer. 2014. PMID: 24501009 Free PMC article. Clinical Trial.

3

Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors.

Kris MG, Camidge DR, Giaccone G, Hida T, Li BT, O'Connell J, Taylor I, Zhang H, Arcila ME, Goldberg Z, Jänne PA. Kris MG, et al. Among authors: giaccone g. Ann Oncol. 2015 Jul;26(7):1421-7. doi: 10.1093/annonc/mdv186. Epub 2015 Apr 21. Ann Oncol. 2015. PMID: 25899785 Free PMC article. Clinical Trial.

4

Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.

Carter CA, Rajan A, Keen C, Szabo E, Khozin S, Thomas A, Brzezniak C, Guha U, Doyle LA, Steinberg SM, Xi L, Raffeld M, Tomita Y, Lee MJ, Lee S, Trepel JB, Reckamp KL, Koehler S, Gitlitz B, Salgia R, Gandara D, Vokes E, Giaccone G. Carter CA, et al. Among authors: giaccone g. Ann Oncol. 2016 Apr;27(4):693-9. doi: 10.1093/annonc/mdw008. Epub 2016 Jan 22. Ann Oncol. 2016. PMID: 26802155 Free PMC article.

5

Combined Small Cell Carcinoma of the Lung: Is It a Single Entity?

Zhao X, McCutcheon JN, Kallakury B, Chahine JJ, Pratt D, Raffeld M, Chen Y, Wang C, Giaccone G. Zhao X, et al. Among authors: giaccone g. J Thorac Oncol. 2018 Feb;13(2):237-245. doi: 10.1016/j.jtho.2017.10.010. Epub 2017 Oct 31. J Thorac Oncol. 2018. PMID: 29101056 Free PMC article.

6

Surgical Resection of SCLC: Prognostic Factors and the Tumor Microenvironment.

Zhao X, Kallakury B, Chahine JJ, Hartmann D, Zhang Y, Chen Y, Zhang H, Zhang B, Wang C, Giaccone G. Zhao X, et al. Among authors: giaccone g. J Thorac Oncol. 2019 May;14(5):914-923. doi: 10.1016/j.jtho.2019.01.019. Epub 2019 Feb 5. J Thorac Oncol. 2019. PMID: 30735815 Free PMC article.

7

TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells.

Zhu J, Liu W, Chen C, Zhang H, Yue D, Li C, Zhang L, Gao L, Huo Y, Liu C, Giaccone G, Zhang B, Wang C. Zhu J, et al. Among authors: giaccone g. J Cancer Res Clin Oncol. 2019 Jun;145(6):1509-1519. doi: 10.1007/s00432-019-02921-3. Epub 2019 Apr 23. J Cancer Res Clin Oncol. 2019. PMID: 31016380

8

Circulating tumor DNA detection is correlated to histologic types in patients with early-stage non-small-cell lung cancer.

Zhang B, Niu X, Zhang Q, Wang C, Liu B, Yue D, Li C, Giaccone G, Li S, Gao L, Zhang H, Wang J, Yang H, Wu R, Ni P, Wang C, Ye M, Liu W. Zhang B, et al. Among authors: giaccone g. Lung Cancer. 2019 Aug;134:108-116. doi: 10.1016/j.lungcan.2019.05.034. Epub 2019 May 31. Lung Cancer. 2019. PMID: 31319968

9

Serum CRIPTO does not confer drug resistance against osimertinib but is an indicator of tumor burden in non-small cell lung cancer.

Chen V, Iwama E, Kim IK, Giaccone G. Chen V, et al. Among authors: giaccone g. Lung Cancer. 2020 Jul;145:48-57. doi: 10.1016/j.lungcan.2020.04.032. Epub 2020 May 5. Lung Cancer. 2020. PMID: 32408132 Free article.

10

Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis.

Zhang B, Zhang L, Yue D, Li C, Zhang H, Ye J, Gao L, Zhao X, Chen C, Huo Y, Pang C, Li Y, Chen Y, Chuai S, Zhang Z, Giaccone G, Wang C. Zhang B, et al. Among authors: giaccone g. Transl Lung Cancer Res. 2020 Aug;9(4):1187-1201. doi: 10.21037/tlcr-19-664. Transl Lung Cancer Res. 2020. PMID: 32953497 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

978 results

Search Page